Best Agrolife
- P/E
- 17.42
Key Fundamentals
MicrocapFertilizers & AgrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 5.15%
- Debt to Equity
- 0.58
- EPS (TTM)
- ₹0.84
- Book Value
- ₹22.92
- Market Cap
- —
- P/E (TTM)
- 17.42
- P/B
- 0.64
- ROE
- 1.11%
- Dividend Yield
- 0.70%
- EBITDA
- ₹105 Cr
- 52W High
- ₹34.40
- 52W Low
- ₹12.30
- Day Range
- ₹13.95 – ₹14.90
- Volume
- 6,77,408
Peer Comparison
Commodities › Chemicals › Pesticides & Agrochemicals
| ₹529.00 | 22.09 | ₹43,728 Cr | 1.28 | 1.16% | 5.64% | 10.10% | ₹52,804 Cr | ₹2,323 Cr | |
| ₹2,187.00 | 28.48 | ₹33,248 Cr | 2.95 | 0.69% | 11.20% | 15.00% | ₹6,516 Cr | ₹1,164 Cr | |
| ₹328.10 | 28.24 | ₹15,980 Cr | 4.43 | 0.41% | 17.60% | 23.50% | ₹3,192 Cr | ₹581 Cr | |
| ₹3,249.90 | 19.95 | ₹14,602 Cr | 4.92 | 4.57% | 23.70% | 29.10% | ₹5,595 Cr | ₹733 Cr | |
| ₹677.95 | 9.77 | ₹6,015 Cr | 1.88 | 2.23% | 23.20% | 30.20% | ₹5,357 Cr | ₹626 Cr | |
| ₹942.75 | 15.83 | ₹4,217 Cr | 2.50 | 0.21% | 18.50% | 23.80% | ₹1,953 Cr | ₹268 Cr | |
| ₹189.67 | 17.23 | ₹3,734 Cr | 1.68 | 1.58% | 10.20% | 14.10% | ₹2,962 Cr | ₹214 Cr | |
| ₹14.63 | 17.42 | ₹508 Cr | 0.64 | 0.70% | 1.11% | 5.15% | ₹1,272 Cr | ₹30 Cr | |
| Median 8 companies | ₹603.48 | 18.69 | ₹10,309 Cr | 2.19 | 0.93% | 14.40% | 19.25% | ₹4,275 Cr | ₹604 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 75
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 69
- Strong
- Cheap vs sector & own history 24% weight
- Growth
- 3
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 26
- Poor
- Solvency, leverage, coverage 9% weight
- Momentum
- 16
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 48
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Stock is trading at 0.82 times its book value
- Company has been maintaining a healthy dividend payout of 18.9%
Weaknesses
5- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 6.78% over past five years.
- Company has a low return on equity of 8.99% over last 3 years.
- Debtor days have increased from 115 to 142 days.
- Working capital days have increased from 70.0 days to 103 days
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 5 | 2 |
| Oscillators | Bearish | 3 | 5 | 1 |
| Moving Averages | Strong Bearish | 9 | 0 | 1 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 38.69
- Neutral
- MACD (12,26,9)
- −0.93
- Bearish
- SMA (50)
- 17.23
- Bearish
- SMA (200)
- 17.41
- Bearish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 5Y | +6.79% |
|---|---|
| 3Y | −10.37% |
| 1Y | −30.71% |
| TTM | −24.11% |
Net profit
| 5Y | −24.63% |
|---|---|
| 3Y | −63.94% |
| 1Y | −87.14% |
| TTM | −56.52% |
Operating cash flow
| 5Y | +49.47% |
|---|---|
| 3Y | Turned positive |
| 1Y | −57.46% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | +2.32 pp |
|---|---|
| 3Y | −10.02 pp |
| 1Y | −3.07 pp |
| TTM | −0.94 pp |
Revenue by year
| Mar 2017 | ₹127 Cr |
|---|---|
| Mar 2018 | ₹151 Cr |
| Mar 2021 | ₹905 Cr |
| Mar 2022 | ₹1,211 Cr |
| Mar 2023 | ₹1,746 Cr |
| Mar 2024 | ₹1,873 Cr |
| Mar 2025 | ₹1,814 Cr |
| Mar 2026 | ₹1,257 Cr |
Net profit by year
| Mar 2017 | ₹0.00 Cr |
|---|---|
| Mar 2018 | ₹0.00 Cr |
| Mar 2021 | ₹37.00 Cr |
| Mar 2022 | ₹105 Cr |
| Mar 2023 | ₹192 Cr |
| Mar 2024 | ₹106 Cr |
| Mar 2025 | ₹70.00 Cr |
| Mar 2026 | ₹9.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 612 | 811 | 314 | 135 | 519 | 747 | 274 | 274 | 381 | 517 | 203 | 156 | 396 | 407 |
| Expenses | 482 | 667 | 296 | 202 | 465 | 600 | 280 | 270 | 335 | 439 | 199 | 183 | 318 | 307 |
| Operating Profit | 130 | 144 | 19 | −67 | 55 | 147 | −6 | 4 | 46 | 78 | 4 | −27 | 78 | 101 |
| OPM % | 21% | 18% | 6% | −50% | 11% | 20% | −2.1% | 1.6% | 12% | 15% | 1.9% | −17% | 20% | 25% |
| Other Income | 4 | −3 | 1 | 1 | 3 | 1 | 0 | 1 | 4 | −2 | 1 | 1 | 2 | 1 |
| Interest | 12 | 15 | 19 | 15 | 16 | 16 | 16 | 17 | 14 | 13 | 15 | 12 | 15 | 15 |
| Depreciation | 7 | 8 | 6 | 11 | 10 | 10 | 11 | 12 | 10 | 10 | 10 | 10 | 10 | 10 |
| PBT | 115 | 118 | −6 | −92 | 32 | 121 | −33 | −24 | 26 | 52 | −20 | −48 | 55 | 78 |
| Tax % | 21% | 19% | 3% | −22% | 33% | 22% | −26% | −9% | 22% | 26% | −36% | −23% | 26% | 26% |
| Net Profit | 90 | 95 | −7 | −72 | 21 | 95 | −24 | −22 | 20 | 39 | −13 | −37 | 41 | 57 |
| EPS (₹) | 2.55 | 2.67 | −0.19 | −2.04 | 0.6 | 2.67 | −0.68 | −0.62 | 0.56 | 1.1 | −0.36 | −1.05 | 1.15 | — |
Sep 2026: from the results filed on 30 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 127 | 151 | 905 | 1,211 | 1,746 | 1,873 | 1,814 | 1,257 | 1,272 |
| Expenses | 126 | 154 | 854 | 1,045 | 1,432 | 1,648 | 1,614 | 1,157 | 1,140 |
| Operating Profit | 1 | −2 | 51 | 166 | 314 | 226 | 200 | 100 | 132 |
| OPM % | 0.5% | −1.4% | 6% | 14% | 18% | 12% | 11% | 8% | 10% |
| Other Income | 1 | 4 | 7 | 2 | 3 | 3 | 5 | 5 | 2 |
| Interest | 1 | 2 | 5 | 15 | 39 | 62 | 66 | 53 | 55 |
| Depreciation | 0 | 0 | 3 | 12 | 24 | 33 | 43 | 42 | 41 |
| PBT | 0 | 0 | 51 | 141 | 253 | 134 | 96 | 10 | 39 |
| Tax % | 575% | 100% | 27% | 26% | 24% | 21% | 27% | 10% | — |
| Net Profit | 0 | 0 | 37 | 105 | 192 | 106 | 70 | 9 | 30 |
| EPS (₹) | −0.04 | 0 | 1.12 | 2.95 | 5.41 | 2.99 | 1.97 | 0.25 | 0.84 |
| Div. Payout % | 0% | 798% | 12% | 5% | 4% | 7% | 10% | 40% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 22 | 24 | 24 | 24 | 24 | 35 |
| Reserves | 46 | 48 | 108 | 306 | 504 | 623 | 734 | 733 |
| Borrowings | 0 | 19 | 33 | 270 | 568 | 637 | 478 | 442 |
| Other Liabilities | 63 | 35 | 209 | 384 | 380 | 729 | 713 | 470 |
| Total Liabilities | 117 | 110 | 372 | 984 | 1,475 | 2,013 | 1,949 | 1,681 |
| Fixed Assets | 0 | 0 | 19 | 180 | 203 | 362 | 374 | 351 |
| CWIP | 0 | 0 | 4 | 5 | 14 | 15 | 1 | 1 |
| Investments | 32 | 3 | 0 | 0 | 0 | 0 | 1 | 1 |
| Other Assets | 85 | 107 | 349 | 800 | 1,258 | 1,636 | 1,573 | 1,328 |
| Total Assets | 117 | 110 | 372 | 984 | 1,475 | 2,013 | 1,949 | 1,681 |
Cash Flow
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | −14 | −41 | 13 | −60 | −180 | 36 | 228 | 97 |
| Investing | −34 | 31 | 8 | −15 | −19 | −63 | −29 | 1 |
| Financing | 48 | 10 | −11 | 67 | 248 | −1 | −199 | −96 |
| Net Cash Flow | 0 | 0 | 10 | −8 | 49 | −29 | 0 | 2 |
| Free Cash Flow | −14 | −42 | 6 | −66 | −218 | −10 | 208 | 91 |
| CFO/OP | −2,460 | 1,884 | 48 | −13 | −32 | 33 | 123 | 117 |
Ratios
| Particulars | Mar 2017 | Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 85 | 87 | 53 | 77 | 73 | 91 | 113 | 142 |
| Inventory Days | — | — | 67 | 199 | 391 | 864 | 577 | 564 |
| Days Payable | — | — | 72 | 124 | 167 | 521 | 404 | 277 |
| Cash Conversion Cycle | 85 | 87 | 48 | 152 | 297 | 434 | 286 | 430 |
| Working Capital Days | 60 | 150 | 33 | 52 | 47 | 43 | 64 | 103 |
| ROCE % | — | 0% | — | 41% | 34% | 16% | 13% | 5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Best Agrolife insights
65 extracted metrics across FY10–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Concall · Jul 2026Recording
- Q4 FY26 concall · May 2026Transcript PPT Recording
- Q3 FY26 concall · Feb 2026Transcript PPT Recording
- Q2 FY26 concall · Nov 2025Transcript
- 27 May 2026
- 22 Aug 2025
- 1 Jul 2025
- 27 Sep 2024
- 23 Sep 2024
- 19 Jun 2024
- General announcements 1 Nov 2026
Frequently Asked Questions about Best Agrolife
What does Best Agrolife Ltd do?
Where is Best Agrolife Ltd (BESTAGRO) listed?
Which sector does Best Agrolife Ltd belong to?
What is the PE ratio of Best Agrolife Ltd?
What is the 52-week high and low of Best Agrolife Ltd?
Does Best Agrolife Ltd pay dividends?
What is the Return on Equity (ROE) of Best Agrolife Ltd?
Company Information
Best Agrolife (formerly known as Sahyog Multibase Limited) is a leading agrochemicals manufacturer in India and is among the top 15 agrochemicals companies in the country. It is one of the fastest growing manufacturers of Technicals, Formulations, Intermediates and Public Health products. Best Agrochem Private Limited was amalgamated with the Co. in April 2018. It offers more than 70 Formulations in the form of Insecticides, Herbicides, Fungicides and Plant Growth Regulators, which are developed from active ingredients manufactured in-house. As part of its P2P set-up, Best Agrolife caters to several blue-chip corporates and leading MNCs from India and abroad.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BESTAGRO.md for Best Agrolife Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.